OrthoPediatrics (NASDAQ:KIDS) Shares Down 7.8% – Time to Sell?

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) dropped 7.8% during trading on Thursday . The company traded as low as $28.10 and last traded at $28.54. Approximately 46,608 shares changed hands during mid-day trading, a decline of 72% from the average daily volume of 164,730 shares. The stock had previously closed at $30.95.

Wall Street Analyst Weigh In

KIDS has been the topic of a number of research reports. JMP Securities reissued a “market outperform” rating and issued a $50.00 price objective on shares of OrthoPediatrics in a research report on Friday, September 13th. Truist Financial cut their price objective on shares of OrthoPediatrics from $34.00 to $28.00 and set a “hold” rating on the stock in a research report on Monday, October 14th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $42.00 price objective on shares of OrthoPediatrics in a research report on Friday, September 13th.

OrthoPediatrics Price Performance

The company has a debt-to-equity ratio of 0.03, a current ratio of 4.90 and a quick ratio of 1.96. The company’s 50-day simple moving average is $27.96 and its 200-day simple moving average is $29.86. The stock has a market capitalization of $665.53 million, a P/E ratio of -28.39 and a beta of 1.16.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Monday, August 5th. The company reported ($0.23) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.31) by $0.08. OrthoPediatrics had a negative net margin of 14.35% and a negative return on equity of 5.44%. The firm had revenue of $52.80 million for the quarter, compared to analyst estimates of $52.40 million. As a group, sell-side analysts expect that OrthoPediatrics Corp. will post -0.92 EPS for the current fiscal year.

Insider Buying and Selling at OrthoPediatrics

In other OrthoPediatrics news, General Counsel Daniel J. Gerritzen sold 10,000 shares of the company’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $29.30, for a total value of $293,000.00. Following the transaction, the general counsel now directly owns 77,304 shares in the company, valued at $2,265,007.20. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 31.80% of the company’s stock.

Hedge Funds Weigh In On OrthoPediatrics

Institutional investors and hedge funds have recently modified their holdings of the stock. International Assets Investment Management LLC grew its stake in shares of OrthoPediatrics by 2,610.8% in the third quarter. International Assets Investment Management LLC now owns 1,003 shares of the company’s stock valued at $27,000 after acquiring an additional 966 shares in the last quarter. Quest Partners LLC acquired a new position in shares of OrthoPediatrics in the second quarter valued at about $34,000. EntryPoint Capital LLC grew its stake in shares of OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock valued at $81,000 after acquiring an additional 1,009 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of OrthoPediatrics in the second quarter valued at about $110,000. Finally, State Board of Administration of Florida Retirement System acquired a new position in shares of OrthoPediatrics in the first quarter valued at about $178,000. 69.05% of the stock is currently owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.